Eluxadoline Reagent Market In Global
Eluxadoline is a novel, orally-active drug approved for the treatment of diarrhea and abdominal p ... Read More
Eliglustat tartrate is a tartrate that is the hemitartrate salt of eliglustat.
This report contains market size and forecasts of Eliglustat Tartrate API in global, including the following market information:
Global Eliglustat Tartrate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eliglustat Tartrate API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Eliglustat Tartrate API companies in 2021 (%)
The global Eliglustat Tartrate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eliglustat Tartrate API include Tecoland, Biophore, Raks Pharma, Dr. Reddy’s Laboratories, Pharmaffiliates, Symbio Generrics, Clearsynth, Cangzhou Enke Pharma Tech and Hangzhou Utanpharma Biology. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eliglustat Tartrate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eliglustat Tartrate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eliglustat Tartrate API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Eliglustat Tartrate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eliglustat Tartrate API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Eliglustat Tartrate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eliglustat Tartrate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eliglustat Tartrate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eliglustat Tartrate API revenues share in global market, 2021 (%)
Key companies Eliglustat Tartrate API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Eliglustat Tartrate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tecoland
Biophore
Raks Pharma
Dr. Reddy’s Laboratories
Pharmaffiliates
Symbio Generrics
Clearsynth
Cangzhou Enke Pharma Tech
Hangzhou Utanpharma Biology
Eluxadoline is a novel, orally-active drug approved for the treatment of diarrhea and abdominal p ... Read More
Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in in ... Read More
Eslicarbazepine acetate,an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and vol ... Read More
Eslicarbazepine acetate is an anticonvulsant medication approved for use in Europe and the United ... Read More